Bioimpacts. 2015;5(2):87-91. doi: 10.15171/bi.2015.15. Epub 2015 Apr 21.
Detecting the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus.
BioImpacts : BI
Zahra Shokravi, Laleh Mehrad, Ali Ramazani
Affiliations
Affiliations
- Microbiology Department, Faculty of Basic Sciences, Islamic Azad University, Arak, Iran.
- Biotechnology Department, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
PMID: 26191502
PMCID: PMC4492189 DOI: 10.15171/bi.2015.15
Abstract
INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) plays an important role in causing many serious nosocomial infections. In this study, the antimicrobial susceptibility and the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus was investigated from two university hospitals of Zanjan province of Iran.
METHODS: In this study, the antimicrobial susceptibility of MRSA isolates to various antibiotics was investigated by the disk diffusion method. Multiplex PCR assays were used for the determination of aminoglycoside modifying enzyme (AME) genes and staphylococcal cassette chromosome mec (SCCmec) types in MRSA strains.
RESULTS: All 58 MRSA isolates were sensitive to vancomycin. Resistance to penicillin G, oxacilin, gentamicin, erythromycin, clindamycin, kanamycin, and tobramycin was found in 96.4%, 98.3%, 51.7%, 53.4%, 55.2%, 62% and 58.6% of the isolates, respectively. The most prevalent AME genes were aac(6')/aph(2'') (48.3 %) followed by ant(4)-Ia (24%). The aph(3')-Ia gene was the least frequent AME gene among MRSA isolates (19%). Of the 58 tested MRSA isolates, 5 (8.6%) were harboured SCCmec type I, 11 (19%) SCCmec type II, 20 (34.5%) SCCmec type III, 17 (29.3%) SCCmec type IVa, 1 (1.7%) SCCmec type IVb, 2 (3.4%) SCCmec type IVc, 11 (19%) SCCmec type IVd, and, 18 (31%) SCCmec type V. Nineteen isolates were not typeable.
CONCLUSION: In conclusion, the aac (6')/aph (2'') was the most common aminoglycoside modifying enzyme gene and SCCmec type II and V were the most frequent types detected in hospital isolates, respectively.
Keywords: Aminoglycoside modifying enzymes; Methicillin resistance; Staphylococcus aureus
References
- Antimicrob Agents Chemother. 2003 Apr;47(4):1423-6 - PubMed
- J Clin Microbiol. 1998 Mar;36(3):618-23 - PubMed
- J Clin Microbiol. 2001 Sep;39(9):3115-21 - PubMed
- Am J Infect Control. 2013 Mar;41(3):195-8 - PubMed
- J Antimicrob Chemother. 1999 Feb;43(2):253-9 - PubMed
- J Korean Med Sci. 2003 Oct;18(5):631-6 - PubMed
- Microbiol Rev. 1993 Mar;57(1):138-63 - PubMed
- J Clin Microbiol. 2010 Mar;48(3):720-7 - PubMed
- J Med Microbiol. 2008 Jan;57(Pt 1):72-9 - PubMed
- Iran Biomed J. 2013;17 (3):129-33 - PubMed
- Biotechnol Lett. 2006 Jan;28(1):55-9 - PubMed
- Infection. 2009 Feb;37(1):44-8 - PubMed
- J Clin Microbiol. 1998 Aug;36(8):2366-8 - PubMed
- Int J Antimicrob Agents. 2009 Mar;33(3):264-5 - PubMed
- J Clin Microbiol. 2005 Oct;43(10):5026-33 - PubMed
- J Antimicrob Chemother. 2004 Nov;54(5):889-96 - PubMed
- Lancet Infect Dis. 2008 May;8(5):289-301 - PubMed
- Microbiol Res. 2006;161(1):49-54 - PubMed
Publication Types